Target intelligence / Profile preview

Tetratricopeptide repeat domain 39A (TTC39A)

Target
TTC39A
Molecular classification
Other (protein containing tetratricopeptide repeat domains; not classified as receptor, enzyme, transporter, or transcription factor)
01

Overview

Tetratricopeptide repeat domain 39A (TTC39A) is a protein-coding gene located on chromosome 1, encoding a protein that belongs to the tetratricopeptide repeat (TPR) domain family[1][6][8]. Proteins with TPR domains typically function as scaffolding modules mediating protein–protein interactions. TTC39A is localized in the centrosome, though its precise molecular and cellular functions are not well elucidated. There are no widely recognized reports that TTC39A acts as a therapeutic receptor, enzyme, or transporter, and there are no established approved drugs targeting this protein. Its aliases reflect sequence-based identification, differential expression in certain cell lines (notably MCF-7 with estradiol), and alternative gene symbols used in various databases. Current data do not indicate TTC39A is a validated therapeutic target.

Other names
Tetratricopeptide repeat protein 39AC1orf34KIAA0452TPR repeat protein 39ADEME-6Differentially expressed in MCF-7 with estradiol protein 6testicular tissue protein Li 213
02

Biological functions

Protein–protein interactions (mediated by tetratricopeptide repeats)Likely involved in cellular or subcellular localization (notably at the centrosome)Other (specific functions not well characterized in literature)
03

Disease associations

Other (no established disease category, but research may be ongoing in cancer and metabolism due to expression patterns and reported differential expression in MCF-7 with estradiol)

Beyond the preview

Go deeper on Tetratricopeptide repeat domain 39A (TTC39A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tetratricopeptide repeat domain 39A (TTC39A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call